for the bio-sciences sector
A growing need has been identified in the life sciences market for devices capable of creating reproducible in vitro cell hypoxia environments which are deemed vital to the precise analysis of both cell metabolism and function.
Rising to this challenge, Oxford Optronix has developed a novel, cost-effective hypoxia workstation for cell biology applications.
Called HypoxyLab™, this ergonomic and easy to use product provides a localised environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely controlled within a class 2 HEPA-filtered (contamination free), isolation chamber.
HypoxyLab™ will be available for sale in late summer 2013 and is described in detail here.
WellBeing™ clinical trials commence
Happy New Year!
Ed Vaizey MP visits Oxford Optronix
Welcome to our new website!
Spring has sprung
Reflecting on 2016; looking forward to 2017
A little time Down Under…
Latest GelCount software update
Asia distributor workshop
Performance updates for HypoxyLab
Meet us at Genes & Cancer UK, Cambridge
Looking forward to a busy 2015
Oxford Optronix reaches new customers
Strategic tie-up with SciPro Inc., USA
Single-channel OxyFlo™ now shipping
GelCount™ software update
Reflections on 2013
Autumn conference round-up
Our 2013 Customer Survey results are out
Next-generation OxyLite™ and OxyFlo™ monitors